Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Femasys Receives FDA 510(k) Clearance for First Low Pressure HSG Device

November 8, 2011 By AxoGen, Inc.

ATLANTA,
Nov. 7, 2011 /PRNewswire/ — Femasys Inc., an emerging medical device developer
of women’s healthcare solutions, announced today that it has received 510(k)
clearance for the FemChec™ Pressure Management Device, the first device
designed for a low pressure HSG as a confirmation test after a permanent
sterilization procedure is performed. FemChec utilizes patent-pending
technology that limits the applied intrauterine pressure to 200 mmHg, providing
confidence to the physician that he/she will not overpressurize while
adequately filling the uterine cavity and cornu to obtain the required images. FemChec
allows the physician to meet the requirements of the mandatory HSG confirmation
test and may reduce improperly performed tests and procedure complications.

Kathy Lee-Sepsick, Femasys’ President & CEO, commented,
“We have utilized our expertise to respond to the market need for a low
pressure HSG test that can be performed with confidence, taking the guesswork
out of whether low pressure is truly achieved. The FemChec provides clear
benefits to the physician and ultimately the patient as a properly performed
low pressure confirmation test is critical to relying on the permanent
sterilization procedure long-term.”

The FemChec Pressure Management Device will be presented to
the gynecologic community in November at the AAGL meeting in Hollywood, Florida.
Femasys expects the first devices to begin shipping in the U.S. market in
December and is pursuing strategic corporate partnerships for FemChec. The
product is expected to contribute to the growing revenue base of Femasys
branded products. Earlier this year, Femasys launched the FemVue Saline-Air
Device designed to provide gynecologists and their patients with a simple way
to evaluate tubal patency in the office with existing ultrasound. The FemVue product
has been very well received and is being distributed in the U.S. by
Norgenix. The Company is actively seeking other distribution partners for the
rest of the world.

About Femasys

Femasys is a privately held corporation committed to advancing women’s
healthcare with innovative medical devices. The company is continually
researching and developing cost-effective new products designed for women,
often expanding in-office services that physicians can easily incorporate.

Please visit www.femasys.com
and www.femchec.com
for additional information.

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech